Genes associated with telomerase activity levels in esophageal carcinoma cell lines

被引:6
作者
Bergqvist, M [1 ]
Brattström, D
Brodin, D
Lindkvist, A
Dahlman-Wright, K
Dreilich, M
Wagenius, G
Paulsson-Karlsson, Y
机构
[1] Univ Uppsala Hosp, Dept Oncol, S-75185 Uppsala, Sweden
[2] Univ Uppsala Hosp, Dept Genet & Pathol, S-75185 Uppsala, Sweden
[3] Univ Uppsala Hosp, Dept Med Sci, S-75185 Uppsala, Sweden
[4] Halsovagen Huddinge, Dept Biosci Novum, Huddinge, Sweden
来源
DISEASES OF THE ESOPHAGUS | 2006年 / 19卷 / 01期
关键词
cell lines; esophageal cancer; genes; telomerase activity levels;
D O I
10.1111/j.1442-2050.2006.00532.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Telomerase activity levels have been shown to correlate with tumor progression in several malignancies. However, the genetic regulation of telomerase activity levels is not fully understood. The aim of the present study has been to identify a gene expression profile, predicting correlation with the telomerase-activity test. Ten human esophageal carcinoma cell lines were investigated using the telomerase activity assay (TRAPeze(R) Telomerase Detection Kit), followed by further characterization using the GeneChip Human Genome U133A 2.0 Array (Affymetrics Inc., USA), including 14 500 human genes. Telomerase activity levels were detected in all cell lines with a broad range of activity levels. Using a high correlation coefficient, r > 0.90, the following genes were found to be positively correlated with telomerase activity levels: N-myristoyltransferase 2; ribosomal protein L3; retinoblastoma-like 2 (pRb2/p130); and cyclin G2. Only one gene was negatively correlated with telomerase activity levels, zinc finger protein 207. In conclusion, the present microarray data provide primary validation data indicating possible candidates for prognostic and prediction factors in esophageal cancer in relation to telomerase activity.
引用
收藏
页码:20 / 23
页数:4
相关论文
共 23 条
[1]  
Baldi A, 1996, CLIN CANCER RES, V2, P1239
[2]  
Claudio PP, 2000, CANCER RES, V60, P372
[3]   Telomeres, telomerase and cancer: an up-date [J].
Dhaene, K ;
Van Marck, E ;
Parwaresch, R .
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 2000, 437 (01) :1-16
[4]  
Hirashima T, 2001, ANTICANCER RES, V21, P3685
[5]   Telomerase as tumor marker [J].
Hiyama, E ;
Hiyama, K .
CANCER LETTERS, 2003, 194 (02) :221-233
[6]  
HIYAMA K, 1995, J IMMUNOL, V155, P3711
[7]   Cyclin G2 is up-regulated during growth inhibition and B cell antigen receptor-mediated cell cycle arrest [J].
Horne, MC ;
Donaldson, KL ;
Goolsby, GL ;
Tran, D ;
Mulheisen, M ;
Hell, JW ;
Wahl, AF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (19) :12650-12661
[8]  
Huynh H, 2004, INT J ONCOL, V25, P1839
[9]   SPECIFIC ASSOCIATION OF HUMAN TELOMERASE ACTIVITY WITH IMMORTAL CELLS AND CANCER [J].
KIM, NW ;
PIATYSZEK, MA ;
PROWSE, KR ;
HARLEY, CB ;
WEST, MD ;
HO, PLC ;
COVIELLO, GM ;
WRIGHT, WE ;
WEINRICH, SL ;
SHAY, JW .
SCIENCE, 1994, 266 (5193) :2011-2015
[10]  
Kudoh K, 2000, CANCER RES, V60, P4161